NCT01969188View on ClinicalTrials.gov

A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement

Active, not recruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Spondyloarthritis

Trial Locations (1)

10021

Hospital for Special Surgery, New York

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Hospital for Special Surgery, New York

OTHER